• NEBANNER

2-((6-chloro-3-Methyl-2,4-dioxo-3,4-dihydropyriMidin-1(2H)-yl)Methyl)-4-fluorobenzonitrile

2-((6-chloro-3-Methyl-2,4-dioxo-3,4-dihydropyriMidin-1(2H)-yl)Methyl)-4-fluorobenzonitrile

Lus piav qhia luv luv:

CAS no865759-24-6

Cov khoom siv tshuaj: Trelagliptin succinate Intermediates


Product Detail

Khoom cim npe

Siv

2-((6-chloro-3-Methyl-2,4-dioxo-3,4-dihydropyriMidin-1(2H)-yl)Methyl)-4-fluorobenzonitrile yog siv los ua qhov nruab nrab ntawm Trelagliptin succinate.
Trogliptin succinate yog dipeptidyl peptidase Ⅳ (DPP - Ⅳ) inhibitor tsim los ntawm Takeda (Takeda Pharmaceutical Co., Ltd.) hauv Nyiv.Nws tuaj yeem xaiv thiab tsis tu ncua inhibit DPP - Ⅳ thiab tswj cov ntshav qabzib.Kev sim tshuaj ntsuam xyuas qhia tau tias cov tshuaj muaj kev nyab xeeb thiab ua haujlwm zoo.Ib zaug ib lub lim tiam tuaj yeem tswj cov ntshav qabzib zoo thiab txhim kho cov tshuaj ua raws li cov neeg mob.Thaum lub Tsib Hlis, 2015, cov tshuaj tau pom zoo los ntawm Nyiv PMDA kom tau teev npe rau kev kho mob ntshav qab zib.

Resource-integrated Product Line

wps_doc_0

Daim ntawv pov thawj

JIN DUN Medical muajISO tsim nyog thiab ua tau raws li GMP cov qauv tsim, ua hauj lwm hauv tsev thiab txawv teb chaws cov kws kho tshuaj synthesis nrog kev nplua nuj los coj lub tuam txhab R & D.

13
d68590 ua
12
111

Qhov zoo ntawm Kev Kho Mob Customization

TECHNOL OGY ADVANTAGES
● High Pressure Catalytic Hydrogenation .High Pressure Hydrogenolysis Reaction.Cryogenic cov tshuaj tiv thaiv (<-78% C)
●Aromatic Heterocyclic Synthesis
● Kev Ruaj Ntseg Tsis Zoo
● Chiral Resolution
●Heck, Suzuki, Negishi, Sonogashira .Gignard Reaction

JIN DUN R&D

Cov khoom siv

Peb lub Lab muaj ntau yam kev sim thiab ntsuas cov cuab yeej, xws li: NMR (Bruker 400M), HPLC, chiral-HPLC, LC-MS, LC-MS/MS (API 4000), IR, UV, GC, GC-MS, Chromatography, Microwave Synthesizer, Parallel Synthesizer, Differential Scanning Calorimeter (DSC), Electron Microscope ...

Pab neeg R&D

Jindun Kev Kho Mob muaj ib pab pawg kws tshaj lij R & D cov neeg ua haujlwm, thiab ntiav ntau tus kws tshaj lij kev siv tshuaj hauv tsev thiab txawv teb chaws los coj R&D, ua rau peb cov khoom sib xyaw ua kom raug thiab ua tau zoo.

wps_doc_3

Case-Sib koom

Peb tau pab ntau lub tuam txhab tshuaj hauv tsev sab saum toj, xws liHansoh, Hengrui thiab HEC Pharm.Ntawm no peb yuav qhia ib feem ntawm lawv.

wps_doc_4

Customzation Case Ib:

CAS Nr .: 110351-94-5

wps_doc_5

Customzation Case Ob:

CAS Nr .: 144848-24-8

wps_doc_6

Customzation Case Peb:

CAS Nr .: 200636-54-0

Kev koom tes hom

1.Customize New Intermediates lossis APIs.Ib yam li cov ntaub ntawv sib qhia saum toj no, cov neeg siv khoom muaj qhov xav tau tshwj xeeb Intermediates lossis APIs, thiab lawv nrhiav tsis tau cov khoom xav tau hauv khw, ces peb tuaj yeem pab kho.

2.Txheej txheem Optimization rau cov khoom qub.Peb pab neeg yuav pab Optimize thiab txhim kho xws li ntau lawm uas nws cov tshuaj tiv thaiv txoj kev yog qub, ntau lawm nqi yog siab, thiab efficiency yog tsawg.Peb tuaj yeem muab cov ntaub ntawv tag nrho rau kev hloov pauv thev naus laus zis thiab kev txhim kho cov txheej txheem, pab cov neeg siv khoom kom muaj txiaj ntsig ntau dua.

Los ntawm cov hom phiaj tshuaj rau INDs, JIN DUN Kev Kho Mob muab rau kojib-nres tus kheej R & D kev daws teeb meem.

JIN DUN Kev Kho Mob hais kom tsim ib pab neeg nrog kev npau suav, ua cov khoom muaj txiaj ntsig, ua kom zoo, nruj, thiab tawm mus ua ib tus neeg ntseeg siab thiab phooj ywg ntawm cov neeg siv khoom!


  • Yav dhau los:
  • Tom ntej:

  • Sau koj cov lus ntawm no thiab xa tuaj rau peb